D
Crinetics Pharmaceuticals, Inc. CRNX
$34.47 -$0.57-1.63%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 0.00 -- 399.00K 640.00K 0.00
Total Other Revenue -- -- -- -- --
Total Revenue 0.00 -- 399.00K 640.00K 0.00
Cost of Revenue 66.57M 61.91M 58.34M 53.34M 45.58M
Gross Profit -66.57M -61.91M -57.95M -52.70M -45.58M
SG&A Expenses 28.18M 25.89M 24.84M 20.83M 17.08M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 94.75M 87.80M 83.18M 74.17M 62.66M
Operating Income -94.75M -87.80M -82.78M -73.53M -62.66M
Income Before Tax -80.60M -76.83M -74.06M -66.93M -60.10M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -80.60M -76.83M -74.06M -66.93M -60.10M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -80.60M -76.83M -74.06M -66.93M -60.10M
EBIT -94.75M -87.80M -82.78M -73.53M -62.66M
EBITDA -93.96M -87.03M -82.03M -73.06M -62.40M
EPS Basic -0.88 -0.96 -0.94 -0.93 -0.90
Normalized Basic EPS -0.55 -0.60 -0.59 -0.58 -0.56
EPS Diluted -0.88 -0.96 -0.94 -0.93 -0.90
Normalized Diluted EPS -0.55 -0.60 -0.59 -0.58 -0.56
Average Basic Shares Outstanding 91.49M 80.09M 79.01M 72.29M 67.15M
Average Diluted Shares Outstanding 91.49M 80.09M 79.01M 72.29M 67.15M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings